What changed at MKM in April, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The Supply Chain Dispatch
What changed at GL Biochem in January, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
GL Biochem has again declined to identify the facility that synthesises the material it sells. The Journal has now put the question in writing on 4 occasions since 2025, in each case asking only for the name of the synthesis house or an acknowledgement that the company is a reseller. The replies have been courteous and have addressed a different question.
The Journal’s written requests are dated across 4 quarters and were sent to the address the company publishes for commercial enquiries. Four received a reply within a fortnight. Each reply restated the company’s quality claims and none named a facility. One offered a video call, which the Journal declined on the grounds that a video call produces nothing publishable.
The distinction that matters here is between a company that will not answer and a company that cannot. A reseller with no visibility into its own supply chain is in a different position from a manufacturer protecting a process, and the two are indistinguishable from the outside — which is precisely why the Journal reports the count of unanswered requests rather than an inference about the reason.
"Printing the threshold costs them nothing and it is the single most useful line you can add," said Dr Ingrid Haldorsen, clinical epidemiologist. "It converts a number you have to trust into a number you can check."
The change has been recorded in GL Biochem’s dossier, which is reviewed quarterly. Readers holding certificates from this supplier are invited to send them to the standards desk; we compare document sets across time and publish what changes.
Note
Each dossier links the company’s own storefront, marked nofollow and sponsored, so a reader can check a claim against the seller’s own copy. The Journal sells nothing, takes no commission on any transaction, and a link is not a recommendation.
Related coverage
Denmark health authority warns on falsified semaglutide pens
Reported from the analysis, not from a warning notice.
Four ways a peptide comes apart
We describe each pathway in enough chemical detail to explain why it is invisible to the method the trade uses, because that is the part which has practical consequences.
What a 37% rise in coupling-reagent prices does to a 2 mg vial
Follow the resin, not the catalogue.
What changed at WWB in May, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Retest date, expiry date, and the two conventions being confused
A document is only as good as the chain that connects it to the material, and most chains here are two or three links longer than the paperwork admits.